Aptar Pharma and Pulmotree Collaborate to Develop and Promote Kolibri Non-Propellant Liquid Inhaler Platform
Aptar Pharma, a global leader in drug delivery and active material science solutions and services, recently announced that it has entered into an exclusive collaboration agreement with PULMOTREE to lead the development and promotion of their Kolibri™ Non-Propellant Liquid Inhaler (NPLI) platform. As part of the agreement, Aptar Pharma will provide PULMOTREE with their full […]
